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INTRODUCTION 
Uric acid is a product that produces from genetic 
excretion and purine metabolism, but the cause of gout is 
food that is rich in purines, alcohol consumption and 
being overweight (Tausche et al., 2009; Maiuolo et al., 
2016). When uric acid levels increase it will cause 
discomfort and it’s associated with hypertension, and 
cardiovascular disease (Kutzing & Firestein, 2008; de 
Oliveira & Burini, 2012; Avarez-Lario & Macarrón-
Vicente, 2011). The increasing uric acid levels can cause 
urate saturation, the formation of monosodium urate 
crystals, and the interaction of monosodium urate 
crystals with leukocytes that lead to acute grout arthritis 
(Martillo et al., 2014; Suresh, 2005). Normal levels of uric 
acid in the blood based on sex in adults is 7.0 mg/ dL for 
men and 6.0 mg/dL for women (Jin et al., 2012; Shani et 
al., 2016). 
Gout is often called arthritis gout because it is caused by 
high levels of uric acid in the blood. High levels of uric 
acid in the blood that exceeds normal limits can cause the 
accumulation of uric acid in the joints and other body 
organs (Avarez-Lario & Macarrón-Vicente, 2011). Uric 
acid which has accumulated can cause joint pain, pain, 
and inflammation (Roddy & Choi, 2014). Further effects 
of arthritis gout are the inability to walk, joint pain when 
moving, experiencing damage to the joints, and can even 
cause people with disabilities (Ragab et al., 2017; Lv et al., 
2019; Grygiel-Górniak & Puszczewicz, 2014). This 
increasing prevalence is associated with gender risk 
factors, intake of a purine-rich diet (Kanbara & Seyama, 
2011), alcohol, obesity, hypertension, impaired kidney 
function, and genetic factors (Ragab et al., 2017; Benn et al., 
2018). 
The medications commonly used are allopurinol and 
febuxostat because due to their mechanism by inhibiting 
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 Abstract 
Uric acid is the final product of purine metabolism that will be 
excreted through urine, feces, and sweat. Excessive production of uric 
acid can cause hyperuricemia, known as gout. The skin of shallots 
(Allium cepa L.) is one of the household wastes that are very rarely used 
by the community. Ethanol extract of shallot skin (EESS) was tested 
for phytochemical screening and anti-hyperuricemia activity using 
potassium oxonate. Mice were divided into five groups (Allopurinol, 
Na-CMC, EESS 200 mg/kg BW, 300 mg/kg BW, and 400 mg/kg BW) 
and uric acid levels were observed at 2-hour intervals for six hours. 
Phytochemical screening shows that EESS has potential compounds in 
the treatment of gout. Tests to reduce uric acid levels showed that 
EESS has better potential than allopurinol at concentrations of 300 
mg/kg BW and 400 mg/kg BW after six hours of induction in reducing 
uric acid levels. 
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xanthine activity in reducing uric acid levels (Chen et al., 
2019; McDonagh et al., 2014). Traditionally, natural 
compounds are believed to have the potential to reduce 
uric acid levels (Lv et al., 2019). One of the natural 
ingredients that are reported to be investigated for its 
potential activity as an acid-lowering uric acid level is the 
shallot (Allium cepa L.). The shallot has flavonoids 
(quercetin) and other phenolics. Quercetin and phenolics 
are believed to have the potential to reduce uric acid 
levels (Rahmat et al., 2018). This study aim is to test the 
potential of ethanol extract from shallot skin on the uric 
acid levels which is tested in vivo on male white mice 
(Mus musculus). 
 
MATERIALS AND METHODS 
Plant collection 
Fresh shallot (Figure 1) was collected from the local area 
of Medan, North Sumatra, Indonesia and authenticated 
by Herbarium Medanense, Faculty of Mathematics and 
Natural Science, Universitas Sumatera Utara, Indonesia 
(No.2329/MEDA/2018). Fresh leaf of shallot skins was 
dried by aerating at room temperature and avoiding 
direct sunlight. The dried shallot skin then powdered by 
mechanical milled. 
 
(a)    (b) 
Figure 1. Shallot peels in the form of (a) dried and (b) simplicia 
powder 
 
Preparation of ethanol extract of shallot skin 
About 1,000 g of the dried shallot skin powder was 
extracted with 96% ethanol by using the maceration 
method for five days at room temperature. The ethanol 
extract of shallot skin (EESS) solution part was 
evaporated by using a rotary evaporator at 50°C to obtain 
the crude extract (Adawia et al., 2016). 
Preliminary phytochemical screening 
The crude EESS was screened by using the standard 
protocol of phytochemical screening to see the presence 
of phytochemical compounds. Alkaloids are detected by 
Dragendorff's test, flavonoids with Salkowski test, 
saponins with the frothing test, tannins with ferric 
chloride test, and steroids as well as terpenoids with 
Salkowski test (Adawia et al., 2016; Haro et al., 2018). 
Animal preparation 
Healthy adult white male mice (± 25 g) were obtained 
from Animal House of Sekolah Tinggi Ilmu Kesehatan 
Senior Medan, Indonesia. Mice were housed in 
polycarbonate cages at room temperature with 12 hours 
day-night circle and feed on standard animal pellets and 
water freely. This study was conducted according to the 
ethical norms by the National Health Research Ethics 
Committees and was approved by the National Health 
Research Ethics Committees, Faculty of Mathematics and 
Natural Science, Universitas Sumatra Utara (No. 
0401/KEPH-FMIPA/2019). The animals were fasted for 
12 hours before experimentation but allowed free access 
to water. 
Anti-hyperuricemia activity 
Test animals were divided into five groups, each 
consisting of five mice. Determination of dose refers to 
previous research by modifying previous research by 
Ningsih and Fahrudin (2018): 
Group I : Allopurinol suspension with 10 mg/kg BW 
Group II : 1% Na-CMC 
Group III : suspension of EESS with 200 mg/kg BW 
Group IV : suspension of EESS with 300 mg/kg BW 
Group V : suspension of EESS with 400 mg/kg BW 
Firstly, the level of uric acid was measured. Then, each 
mice was induced by potassium oxonate 
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intraperitoneally. Two hours later, uric acid levels were 
measured again in each of each group of mice, then oral 
preparations of each group were given. The uric acid 
level was measured again after four hours and six hours. 
Data were analyzed statistically by used ANOVA and 
Tukey's HSD tests with significantly different (p <0.05). 
 
RESULTS AND DISCUSSION 
Preliminary phytochemical screening 
Phytochemical screening is performed to determine the 
content of the secondary metabolites presented in Table 
I. It is predicted that the flavonoids contained in the EESS 
will have the effect of reducing uric acid levels. The ability 
of this compound to reduce uric acid is inhibited by the 
mechanism of xanthine oxidase activity in the purine 
base to inhibit the production of uric acid and prevent 
inflammation of the joints (Ewadh et al., 2015). Besides, 
the presence of various components of bioactive 
compounds is considered to have uric acid-lowering 
activity (Bakar et al., 2018). 
Table I. Phytochemical screening of EESS 
Phytochemical compounds Results 
Alkaloids + 
Flavonoids + 
Saponins + 
Tannins + 
Steroids/Triterpenoids + 
 
Anti-hyperuricemia activity 
In this study, treatment was divided into five groups: the 
negative control group with 1% Na-CMC suspension, 
the EESS treatment group with three concentration 
variations (200, 300, and 400 mg/kg BW), and the 
positive control group with 10 mg/kg BW of allopurinol. 
Test animals are induced by potassium oxonate to 
develop hyperuricemia. Potassium oxonate has the 
function of increasing uric acid levels (Garcia-Arroyo et 
al., 2018; Oh et al., 2019). The first measurement is taken 
when the test animal is fasted, followed by the induction 
of potassium oxonate. The second measurement was 
taken after two hours of induction. After the uric acid 
measurement data were obtained, treatment was given 
to each group. The third measurement is performed after 
the next two hours (four hours after induction and 
treatment). The fourth measurement after the next two 
hours (six hours after induction) and treatment are 
shown in Table II. 
Table II. Uric acid level in various treatment 
Group 
Fasting 
uric acid 
level 
(mg/dL) 
Uric acid level (mg/dL) 
2 hours 4 hours 6 hours 
I 3.14 ± 0.055 4.64 ± 0.602* 4.24 ± 0.568* 3.8 ± 0.604** 
II 3.14 ± 0.033 4.5 ± 0.4 4.5 ± 0.4 4.48 ± 0.444 
III 3.14 ± 0.27 4.42 ± 0.35* 3.74 ± 0.195* 3.16 ± 0.055** 
IV 3.14 ± 0.114 4.78 ± 0.415* 3.24 ± 0.560*** 2.4 ± 0.071*** 
V 3.14 ± 0.089 4.68 ± 0.683* 2.86 ± 0.358*** 1.34 ± 0.114*** 
Result are expressed as mean ± SD; n = 5; *p >0.05; **p <0.05; ***more 
significant comparing with allopurinol 
 
Observation and measurement of the EESS treatment 
groups with three concentration variations (200, 300, and 
400 mg/kg BW) in animal tests for anti-hyperuricemia 
activity. Bioactive content was present in the EESS, such 
as phenols, flavonoids, flavonoids, and others containing 
decreasing levels of uric acid, as reported by Benítez et al. 
(2011). Bioactive components, particularly phenols and 
flavonoids, are supported by acting as an inhibitor of 
xanthine enzyme oxidation, which works to reduce uric 
acid levels (Oskoueian et al., 2011; Kapoor & Saxena, 
2016). 
Statistical analysis 
Statistical analysis of ANOVA followed by Tukey HSD 
analysis showed that there were differences in the effects 
of EESS treatment on decreased uric acid levels. A 
significant decrease in uric acid levels occurred after four 
hours of induction with allopurinol and EESS with 
concentrations of 300 and 400 mg/kg BW. Measurement 
of uric acid levels after six hours of induction there was a 
significant difference in the administration of allopurinol 
and EESS at concentrations of 200, 300, and 400 mg/kg 
BW, where EESS at concentrations of 300 and 400 mg/kg 
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BW showed better activity than allopurinol. The results 
obtained are different from those reported by Haidari et 
al. (2008), who reported that A. cepa skin juice has lower 
anti-hyperuricemia activity than allopurinol. 
Based on previous research, the results of the analysis by 
HPLC showed that phenolic, flavonoid, and flavanol 
compounds were the most abundant compounds in each 
part of shallot. Each section was reported to show 
antioxidant activity by testing the ability to reduce iron 
using measurements with UV-Vis spectrophotometry. 
The content of flavonoid compounds, phenolics, 
flavanols, quercetin (Benítez et al., 2011), and polyphenols 
are responsible for antioxidant activity and lowering uric 
acid levels from the shallot and has been tested both in 
vivo as well as clinical trials (Ouyang et al., 2018). 
 
CONCLUSION 
Phytochemical screening at EESS contains various 
potential bioactive compounds (alkaloids, flavonoids, 
saponins, tannins, and steroid/triterpenoids) as anti-
hyperuricemia. Ethanol extract of shallot skin showing 
activity at doses of 300 mg/kg BW and 400 mg/kg BW 
better than allopurinol to reduce uric acid levels which 
were tried in male white mice after induction of 
potassium oxonates. 
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